Advances in drug therapies for cytomegalovirus in transplantation: a focus on maribavir and letermovir
© 2020 Informa UK Limited, trading as Taylor & Francis Group. Introduction: Cytomegalovirus (CMV) challenges physicians who care for immunocompromised transplant recipients. Antiviral drugs are the cornerstone in the prevention and treatment of CMV disease, but they have toxicities that limit...
Saved in:
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/60048 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|